Doctor Hidekazu Kondo
Hasama Campus - Faculty of Medicine, Oita University, Yufu City (Japan)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Empagliflozin suppresses the differentiation/maturation of human epicardial preadipocytes and improves paracrine secretome profile
Event: ESC Congress 2023
Topic: Antidiabetic Pharmacotherapy
Session: Improving outcomes in heart failure: bench to bedside
Direct effects of canagliflozin on human myocardial redox signalling: a novel role for SGLT1 inhibition
Event: ESC Congress 2020
Topic: Antidiabetic Pharmacotherapy
Session: Improving Cardiovascular Function and Clinical Outcome in Diabetes Using New Guideline-Based Pharmacotherapy
Novel direct effects of SGLT2 inhibitor, Canagliflozin, on myocardial redox state in humans.
Event: ESC Congress 2019
Topic: Antidiabetic Pharmacotherapy
Session: Pharmacotherapy of diabetes: from bench to bedside
Interleukin-10 treatment ameliorates high-fat diet-induced inflammatory atrial remodelling and fibrillation
Event: ESC Congress 2018
Topic: Arrhythmias
Session: Mechanisms of cardiac arrhythmias
Remarkable cardioprotective effect of interleukin-10 on sinus node dysfunction caused by streptozotocin-induced hyperglycemia in mice
Event: ESC Congress 2018
Topic: Arrhythmias
Session: Lipids, metabolism
Pulmonary vein antrum isolation by radiofrequency catheter ablation depresses baroreflex sensitivity in association with heart rate variability in patients with paroxysmal atrial fibrillation.
Event: ESC Congress 2017
Topic: Invasive electrophysiological studies
Session: Invasive diagnostics
ESC 365 is supported by
